19,071
Views
121
CrossRef citations to date
0
Altmetric
Research Articles

Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study

, , ORCID Icon, , , , , & ORCID Icon show all
Pages 2857-2872 | Received 29 Mar 2020, Accepted 08 Apr 2020, Published online: 02 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (32)

Yogeshwar Devarakonda, M. V. N. Janaradhan Reddy, R. S. Neethu, Aneesh Chandran & Kirtimaan Syal. (2023) Multi epitope vaccine candidate design against Streptococcus pneumonia. Journal of Biomolecular Structure and Dynamics 41:22, pages 12654-12667.
Read now
Deep Bhowmik, Achyut Bhuyan, Seshan Gunalan, Gugan Kothandan & Diwakar Kumar. (2023) In silico and immunoinformatics based multiepitope subunit vaccine design for protection against visceral leishmaniasis. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-22.
Read now
Md. Jahirul Islam, Md. Siddik Alom, Md. Shahadat Hossain, Md Ackas Ali, Shaila Akter, Shafiqul Islam, M. Obayed Ullah & Mohammad A. Halim. (2023) Unraveling the impact of ORF3a Q57H mutation on SARS-CoV-2: insights from molecular dynamics. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-14.
Read now
Wahiba Ezzemani, Anass Kettani, Subrahmanyam Sappati, Kavya Kondaka, Hicham El Ossmani, Kyoko Tsukiyama-Kohara, Haya Altawalah, Rachid Saile, Michinori Kohara, Soumaya Benjelloun & Sayeh Ezzikouri. (2023) Reverse vaccinology-based prediction of a multi-epitope SARS-CoV-2 vaccine and its tailoring to new coronavirus variants. Journal of Biomolecular Structure and Dynamics 41:11, pages 4917-4938.
Read now
Hamid Reza Jahantigh, Behzad Shahbazi, Hamed Gouklai, Hans Van der Weken, Zahra Gharibi, Zahra Rezaei, Mehri Habibi & Khadijeh Ahmadi. (2023) Design peptide and multi-epitope protein vaccine candidates against monkeypox virus using reverse vaccinology approach: an in-silico study. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-21.
Read now
Chin Peng Lim, Boon Hui Kok, Hui Ting Lim, Candy Chuah, Badarulhisam Abdul Rahman, Abu Bakar Abdul Majeed, Michelle Wykes, Chiuan Herng Leow & Chiuan Yee Leow. (2023) Recent trends in next generation immunoinformatics harnessed for universal coronavirus vaccine design. Pathogens and Global Health 117:2, pages 134-151.
Read now
Abhishek Kumar Verma, Sk. Faisal Ahmed, Md. Shahadat Hossain, Ali Asger Bhojiya, Ankita Mathur, Sudhir K. Upadhyay, Abhishek K. Srivastava, Naveen Kumar Vishvakarma, Mayadhar Barik, Md. Mizanur Rahaman & Newaz Mohammed Bahadur. (2022) Molecular docking and simulation studies of flavonoid compounds against PBP-2a of methicillin‐resistant Staphylococcus aureus . Journal of Biomolecular Structure and Dynamics 40:21, pages 10561-10577.
Read now
Mejdi Snoussi, Alaeddine Redissi, Amor Mosbah, Vincenzo De Feo, Mohd Adnan, Kaïss Aouadi, Mousa Alreshidi, Mitesh Patel, Adel Kadri & Emira Noumi. (2022) Emetine, a potent alkaloid for the treatment of SARS-CoV-2 targeting papain-like protease and non-structural proteins: pharmacokinetics, molecular docking and dynamic studies. Journal of Biomolecular Structure and Dynamics 40:20, pages 10122-10135.
Read now
Vikrant Singh Rajput, Ritika Sharma, Anchala Kumari, Nidhi Vyas, Vijay Prajapati & Abhinav Grover. (2022) Engineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins. Journal of Biomolecular Structure and Dynamics 40:19, pages 9096-9113.
Read now
Mossammad U. C. Sultana, Md. Giash Uddin, Md. Billal Hossain, Md Ackas Ali, Zannatul Ferdous Sonia, Suprio Kamal & Mohammad A. Halim. (2022) Molecular dynamics investigation of ivermectin bound to importin alpha/beta heterodimer. Molecular Simulation 48:4, pages 314-321.
Read now
Soumita Mukherjee, Subrata Dasgupta, Tapasendra Adhikary, Utpal Adhikari & Sujit Sankar Panja. (2021) Structural insight to hydroxychloroquine-3C-like proteinase complexation from SARS-CoV-2: inhibitor modelling study through molecular docking and MD-simulation study. Journal of Biomolecular Structure and Dynamics 39:18, pages 7322-7334.
Read now
Nima Razzaghi-Asl, Ahmad Ebadi, Sara Shahabipour & Danial Gholamin. (2021) Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis. Journal of Biomolecular Structure and Dynamics 39:17, pages 6633-6648.
Read now
Maria da Conceição Viana Invenção, Alanne Rayssa da Silva Melo, Larissa Silva de Macêdo, Thaís Souto Paula da Costa Neves, Cristiane Moutinho Lagos de Melo, Marcelo Nazário Cordeiro, Marcus Vinicius de Aragão Batista & Antonio Carlos de Freitas. (2021) Development of synthetic antigen vaccines for COVID-19. Human Vaccines & Immunotherapeutics 17:11, pages 3855-3870.
Read now
Elham Tazikeh-Lemeski, Sajad Moradi, Rahim Raoufi, Mohsen Shahlaei, Mehr Ali Mahmood Janlou & Samaneh Zolghadri. (2021) Targeting SARS-COV-2 non-structural protein 16: a virtual drug repurposing study. Journal of Biomolecular Structure and Dynamics 39:13, pages 4633-4646.
Read now
Mark Tristan J. Quimque, Kin Israel R. Notarte, Rey Arturo T. Fernandez, Mark Andrew O. Mendoza, Rhenz Alfred D. Liman, Justin Allen K. Lim, Luis Agustin E. Pilapil, Jehiel Karsten H. Ong, Adriel M. Pastrana, Abbas Khan, Dong-Qing Wei & Allan Patrick G. Macabeo. (2021) Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms. Journal of Biomolecular Structure and Dynamics 39:12, pages 4316-4333.
Read now
Muhammad Hamza, Ashaq Ali, Suliman Khan, Saeed Ahmed, Zarlish Attique, Saad Ur Rehman, Ayesha Khan, Hussain Ali, Muhammad Rizwan, Anum Munir, Arshad Mehmood Khan, Faiza Siddique, Azhar Mehmood, Faisal Nouroz & Sajid Khan. (2021) nCOV-19 peptides mass fingerprinting identification, binding, and blocking of inhibitors flavonoids and anthraquinone of Moringa oleifera and hydroxychloroquine. Journal of Biomolecular Structure and Dynamics 39:11, pages 4089-4099.
Read now
Anuj Kumar, Gourav Choudhir, Sanjeev Kumar Shukla, Mansi Sharma, Pankaj Tyagi, Arvind Bhushan & Madhu Rathore. (2021) Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. Journal of Biomolecular Structure and Dynamics 39:10, pages 3760-3770.
Read now
Satyajit Beura & Prabhakar Chetti. (2021) In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:10, pages 3747-3759.
Read now
Md Fulbabu Sk, Rajarshi Roy, Nisha Amarnath Jonniya, Sayan Poddar & Parimal Kar. (2021) Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations. Journal of Biomolecular Structure and Dynamics 39:10, pages 3649-3661.
Read now
Khalid El Asnaoui & Youness Chawki. (2021) Using X-ray images and deep learning for automated detection of coronavirus disease. Journal of Biomolecular Structure and Dynamics 39:10, pages 3615-3626.
Read now
Akinwunmi O. Adeoye, Babatunde Joseph Oso, Ige Francis Olaoye, Habibu Tijjani & Ahmed I. Adebayo. (2021) Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus. Journal of Biomolecular Structure and Dynamics 39:10, pages 3469-3479.
Read now
Naún Lobo-Galo, Manuel Terrazas-López, Alejandro Martínez-Martínez & Ángel Gabriel Díaz-Sánchez. (2021) FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication. Journal of Biomolecular Structure and Dynamics 39:9, pages 3419-3427.
Read now
Khattab Al-Khafaji, Dunya AL-Duhaidahawi & Tugba Taskin Tok. (2021) Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:9, pages 3387-3395.
Read now
Sourav Das, Sharat Sarmah, Sona Lyndem & Atanu Singha Roy. (2021) An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics 39:9, pages 3347-3357.
Read now
Imane Abdelli, Faiçal Hassani, Sohayb Bekkel Brikci & Said Ghalem. (2021) In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria. Journal of Biomolecular Structure and Dynamics 39:9, pages 3263-3276.
Read now
Hussain Mustatab Wahedi, Sajjad Ahmad & Sumra Wajid Abbasi. (2021) Stilbene-based natural compounds as promising drug candidates against COVID-19. Journal of Biomolecular Structure and Dynamics 39:9, pages 3225-3234.
Read now
Saurabh K. Sinha, Anshul Shakya, Satyendra K. Prasad, Shashikant Singh, Nilambari S. Gurav, Rupali S. Prasad & Shailendra S. Gurav. (2021) An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. Journal of Biomolecular Structure and Dynamics 39:9, pages 3244-3255.
Read now
Rajib Islam, Md. Rimon Parves, Archi Sundar Paul, Nizam Uddin, Md. Sajjadur Rahman, Abdulla Al Mamun, Md. Nayeem Hossain, Md. Ackas Ali & Mohammad A. Halim. (2021) A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:9, pages 3213-3224.
Read now
Abdo A. Elfiky. (2021) SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective. Journal of Biomolecular Structure and Dynamics 39:9, pages 3204-3212.
Read now
Arafat Hussain, Suniti Yadav, Vijay Hadda, Tejas M Suri, Pawan Tiwari, Saurabh Mittal, Karan Madan & Anant Mohan. (2020) Covid-19: a comprehensive review of a formidable foe and the road ahead. Expert Review of Respiratory Medicine 14:9, pages 869-879.
Read now
Soumya Ranjan Mahapatra, Susrita Sahoo, Budheswar Dehury, Vishakha Raina, Shubhransu Patro, Namrata Misra & Mrutyunjay Suar. (2020) Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection. Expert Review of Vaccines 19:9, pages 871-885.
Read now

Articles from other publishers (89)

Subhashree Mohapatra, Santosh Kumar, Shashank Kumar, Atul Kumar Singh & Bismita Nayak. (2023) Immunodominant conserved moieties on spike protein of SARS-CoV-2 renders virulence factor for the design of epitope-based peptide vaccines. VirusDisease 34:4, pages 456-482.
Crossref
Pejman Hashemzadeh, Saba Asgari nezhad & Hossein Khoshkhabar. (2023) Immunoinformatics analysis of Brucella melitensis to approach a suitable vaccine against brucellosis. Journal of Genetic Engineering and Biotechnology 21:1.
Crossref
Mutaib M. Mashraqi, Ahmad Alzamami, Norah A. Alturki, Hassan H. Almasaudi, Ibrar Ahmed, Saleh Alshamrani & Zarrin Basharat. (2023) Chimeric vaccine design against the conserved TonB-dependent receptor-like β-barrel domain from the outer membrane tbpA and hpuB proteins of Kingella kingae ATCC 23330. Frontiers in Molecular Biosciences 10.
Crossref
Amir Elalouf, Tomer Kedarya, Hadas Elalouf & Ariel Rosenfeld. (2023) Computational design and evaluation of mRNA- and protein-based conjugate vaccines for influenza A and SARS-CoV-2 viruses. Journal of Genetic Engineering and Biotechnology 21:1.
Crossref
Shalini Maurya, Salman Akhtar & Mohammad Kalim Ahmad Khan. (2023) Immunoinformatics Approach for the Design of Chimeric Vaccine Against Whitmore Disease. The Open Bioinformatics Journal 16:1.
Crossref
Saurav Kumar Mishra, Prerna Priya, Gyan Prakash Rai, Rizwanul Haque & Asheesh Shanker. (2023) Coevolution based immunoinformatics approach considering variability of epitopes to combat different strains: A case study using spike protein of SARS-CoV-2. Computers in Biology and Medicine 163, pages 107233.
Crossref
Danillo G. Augusto, Lawton D. Murdolo, Demetra S. M. Chatzileontiadou, Joseph J. SabatinoJrJr, Tasneem Yusufali, Noah D. Peyser, Xochitl Butcher, Kerry Kizer, Karoline Guthrie, Victoria W. Murray, Vivian Pae, Sannidhi Sarvadhavabhatla, Fiona Beltran, Gurjot S. Gill, Kara L. Lynch, Cassandra Yun, Colin T. Maguire, Michael J. Peluso, Rebecca Hoh, Timothy J. Henrich, Steven G. Deeks, Michelle Davidson, Scott Lu, Sarah A. Goldberg, J. Daniel Kelly, Jeffrey N. Martin, Cynthia A. Vierra-Green, Stephen R. Spellman, David J. Langton, Michael J. Dewar-Oldis, Corey Smith, Peter J. Barnard, Sulggi Lee, Gregory M. Marcus, Jeffrey E. Olgin, Mark J. Pletcher, Martin Maiers, Stephanie Gras & Jill A. Hollenbach. (2023) A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. Nature 620:7972, pages 128-136.
Crossref
Kanwal Khalid & Chit Laa Poh. (2023) The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria. Vaccines 11:7, pages 1264.
Crossref
Daniele Santoni. (2023) Peptide Hamming Graphs: A network representation of peptides presented through specific HLAs to identify potential epitope clusters. Journal of Immunological Methods 517, pages 113474.
Crossref
Shahab Mahmoudvand, Hadi Esmaeili Gouvarchin Ghaleh, Farid Azizi Jalilian, Mahdieh Farzanehpour & Ruhollah Dorostkar. (2023) Design of a multi‐epitope‐based vaccine consisted of immunodominant epitopes of structural proteins of SARS‐CoV‐2 using immunoinformatics approach. Biotechnology and Applied Biochemistry 70:3, pages 1189-1205.
Crossref
Rahul Chatterjee, Soumya Ranjan Mahapatra, Jyotirmayee Dey, Kiran Raj Takur, Vishakha Raina, Namrata Misra & Mrutyunjay Suar. (2023) An immunoinformatics and structural vaccinology study to design a multi‐epitope vaccine against Staphylococcus aureus infection . Journal of Molecular Recognition 36:4.
Crossref
Stephen J Goodswen, Paul J Kennedy & John T Ellis. (2023) A guide to current methodology and usage of reverse vaccinology towards in silico vaccine discovery . FEMS Microbiology Reviews 47:2.
Crossref
Harshil Shah, Vivek Chavda & Moinuddin M. Soniwala. 2023. Bioinformatics Tools for Pharmaceutical Drug Product Development. Bioinformatics Tools for Pharmaceutical Drug Product Development 95 116 .
Dimitra S. Mouliou. (2023) The Deceptive COVID-19: Lessons from Common Molecular Diagnostics and a Novel Plan for the Prevention of the Next Pandemic. Diseases 11:1, pages 20.
Crossref
Angelina Kovalenko, Ekaterina Ryabchevskaya, Ekaterina Evtushenko, Nikolai Nikitin & Olga Karpova. (2023) Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress. International Journal of Molecular Sciences 24:2, pages 1701.
Crossref
Victor Chukwudi Osamor, Excellent Ikeakanam, Janet U. Bishung, Theresa N. Abiodun & Raphael Henshaw Ekpo. (2023) COVID-19 Vaccines: Computational tools and Development. Informatics in Medicine Unlocked 37, pages 101164.
Crossref
Binda T. Andongma, Yazheng Huang, Fang Chen, Qing Tang, Min Yang, Shan-Ho Chou, Xinfeng Li & Jin He. (2023) In silico design of a promiscuous chimeric multi-epitope vaccine against Mycobacterium tuberculosis. Computational and Structural Biotechnology Journal 21, pages 991-1004.
Crossref
Maaz Waseem, Amina Basheer, Farha Anwer, Fatima Shahid, Tahreem Zaheer & Amjad Ali. 2023. Omics approaches and technologies in COVID-19. Omics approaches and technologies in COVID-19 23 39 .
Seyyed Amir Siadati, Mehdi Soheilizad, Loghman Firoozpour, Marjan Samadi, Meghdad Payab, Saeed Bagherpour & Seyyed Mehdi Mousavi. (2022) An Industrial Approach to Production of Tofacitinib Citrate (TFC) as an Anti-COVID-19 Agent: A Joint Experimental and Theoretical Study. Journal of Chemistry 2022, pages 1-11.
Crossref
DEVESH D GOSAVI & CHETA N SHINDE. (2022) COVID-19 VACCINES: TARGETS, PRE-CLINICAL STUDIES, MECHANISMS OF ACTION, ADRS, AND ROLLOUT IN INDIA – A JOURNEY SO FAR. Asian Journal of Pharmaceutical and Clinical Research, pages 24-30.
Crossref
Nourelislam Awad, Rania Hassan Mohamed, Nehal I. Ghoneim, Ahmed O. Elmehrath & Nagwa El-Badri. (2022) Immunoinformatics approach of epitope prediction for SARS-CoV-2. Journal of Genetic Engineering and Biotechnology 20:1.
Crossref
Ravichandran Veerasamy & Rohini Karunakaran. (2022) Molecular docking unveils the potential of andrographolide derivatives against COVID-19: an in silico approach. Journal of Genetic Engineering and Biotechnology 20:1.
Crossref
Meet Parmar, Ritik Thumar, Jigar Sheth & Dhaval Patel. (2022) Designing multi-epitope based peptide vaccine targeting spike protein SARS-CoV-2 B1.1.529 (Omicron) variant using computational approaches. Structural Chemistry 33:6, pages 2243-2260.
Crossref
Dominic D. Martinelli. (2022) In silico vaccine design: A tutorial in immunoinformatics. Healthcare Analytics 2, pages 100044.
Crossref
Zakia Salod & Ozayr Mahomed. (2022) Mapping Potential Vaccine Candidates Predicted by VaxiJen for Different Viral Pathogens between 2017–2021—A Scoping Review. Vaccines 10:11, pages 1785.
Crossref
Mojtaba Azimi-Resketi, Saeed Heydaryan, Niloufar Kumar, Azin Takalou, Reza Esmaeelzadeh Dizaji, Bahman Noroozi Gorgani & Morteza Shams. (2022) Computational Clues of Immunogenic Hotspots in Plasmodium falciparum Erythrocytic Stage Vaccine Candidate Antigens: In Silico Approach. BioMed Research International 2022, pages 1-21.
Crossref
Anand Gaurav, Neetu Agrawal, Mayasah Al-Nema & Vertika Gautam. (2022) Computational Approaches in the Discovery and Development of Therapeutic and Prophylactic Agents for Viral Diseases. Current Topics in Medicinal Chemistry 22:26, pages 2190-2206.
Crossref
Narges Farshidi, Tayebeh Ghaedi, Mehdi Hassaniazad, Ebrahim Eftekhar, Hamed Gouklani, Hossein Farshidi, Mohammad Reza Asadi Karam, Behzad Shahbazi, Mehdi Kalani & Khadijeh Ahmadi. (2022) Preparation and pre-clinical evaluation of flagellin-adjuvanted NOM vaccine candidate formulated with Spike protein against SARS-CoV-2 in mouse model. Microbial Pathogenesis 171, pages 105736.
Crossref
Avinash Kumar, Ekta Rathi & Suvarna Ganesh Kini. (2022) Computational design of a broad-spectrum multi-epitope vaccine candidate against seven strains of human coronaviruses. 3 Biotech 12:9.
Crossref
Luis F. Soto, Ana C. Romaní, Gabriel Jiménez-Avalos, Yshoner Silva, Carla M. Ordinola-Ramirez, Rainer M. Lopez Lapa & David Requena. (2022) Immunoinformatic analysis of the whole proteome for vaccine design: An application to Clostridium perfringens. Frontiers in Immunology 13.
Crossref
Mutiat Hammed-Akanmu, Maria Mim, Abdinasir Yusuf Osman, Abdulrahman M. Sheikh, Esmaeil Behmard, Ali A. Rabaan, Rapeah Suppain & Khalid Hajissa. (2022) Designing a Multi-Epitope Vaccine against Toxoplasma gondii: An Immunoinformatics Approach. Vaccines 10:9, pages 1389.
Crossref
Tehniyat Rida, Sajjad Ahmad, Asad Ullah, Saba Ismail, Muhammad Tahir ul Qamar, Zobia Afsheen, Muhammad Khurram, Muhammad Saqib Ishaq, Ali G. Alkhathami, Eid A. Alatawi, Faris Alrumaihi & Khaled S. Allemailem. (2022) Pan-Genome Analysis of Oral Bacterial Pathogens to Predict a Potential Novel Multi-Epitopes Vaccine Candidate. International Journal of Environmental Research and Public Health 19:14, pages 8408.
Crossref
Mohammad Reza Rahbar, Shaden M. H. Mubarak, Anahita Hessami, Bahman Khalesi, Navid Pourzardosht, Saeed Khalili, Kobra Ahmadi Zanoos & Abolfazl Jahangiri. (2022) A unique antigen against SARS-CoV-2, Acinetobacter baumannii, and Pseudomonas aeruginosa. Scientific Reports 12:1.
Crossref
Anoop Kumar, Utkarsha Sahu, Pratima Kumari, Anshuman Dixit & Prashant Khare. (2022) Designing of multi-epitope chimeric vaccine using immunoinformatic platform by targeting oncogenic strain HPV 16 and 18 against cervical cancer. Scientific Reports 12:1.
Crossref
Jacek Plichta, Piotr Kuna & Michał Panek. (2022) Monoclonal Antibodies as Potential COVID-19 Therapeutic Agents. COVID 2:5, pages 599-620.
Crossref
K.A. Saravanan, Manjit Panigrahi, Harshit Kumar, Divya Rajawat, Sonali Sonejita Nayak, Bharat Bhushan & Triveni Dutt. (2022) Role of genomics in combating COVID-19 pandemic. Gene 823, pages 146387.
Crossref
Ekta Gupta, Rupesh Kumar Mishra & Ravi Ranjan Kumar Niraj. (2022) Identification of Potential Vaccine Candidates Against SARS-CoV-2 to Fight COVID-19: Reverse Vaccinology Approach. JMIR Bioinformatics and Biotechnology 3:1, pages e32401.
Crossref
Roba Attar, Eid A. Alatawi, Faris F. Aba Alkhayl, Khloud Nawaf Alharbi, Khaled S. Allemailem & Ahmad Almatroudi. (2022) Immunoinformatics and Biophysics Approaches to Design a Novel Multi-Epitopes Vaccine Design against Staphylococcus auricularis. Vaccines 10:5, pages 637.
Crossref
Yulia Desheva. 2022. Vaccine Development. Vaccine Development.
Zhisong Gao, Lingxiao Chen, Tao Song, Xuan Pan, Xiaojing Li, Guangzong Lu, Yajie Tang, Xiang Wu, Baohua Zhao & Ran Zhang. (2022) A candidate multi-epitope vaccine against porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae induces robust humoral and cellular response in mice. Vaccine 40:16, pages 2370-2378.
Crossref
Abhishek Kumar Verma, Aarfah Majid, Md. Shahadat Hossain, SK. Faisal Ahmed, Mohammad Ashid, Ali Asger Bhojiya, Sudhir K. Upadhyay, Naveen Kumar Vishvakarma & Mudassir Alam. (2022) Identification of 1, 2, 4-Triazine and Its Derivatives Against Lanosterol 14-Demethylase (CYP51) Property of Candida albicans: Influence on the Development of New Antifungal Therapeutic Strategies. Frontiers in Medical Technology 4.
Crossref
Miyo K. Chatanaka, Antigona Ulndreaj, Dorsa Sohaei & Ioannis Prassas. (2022) Immunoinformatics: Pushing the boundaries of immunology research and medicine. ImmunoInformatics 5, pages 100007.
Crossref
Hooman Aghamirza Moghim Aliabadi, Reza Eivazzadeh‐Keihan, Arezoo Beig Parikhani, Sara Fattahi Mehraban, Ali Maleki, Sepideh Fereshteh, Masoume Bazaz, Ashkan Zolriasatein, Bahareh Bozorgnia, Saman Rahmati, Fatemeh Saberi, Zeinab Yousefi Najafabadi, Shadi Damough, Sara Mohseni, Hamid Salehzadeh, Vahid Khakyzadeh, Hamid Madanchi, Gholam Ali Kardar, Payam Zarrintaj, Mohammad Reza Saeb & Masoud Mozafari. (2022) COVID‐19: A systematic review and update on prevention, diagnosis, and treatment. MedComm 3:1.
Crossref
Mohammad Moradi, Reza Golmohammadi, Ali Najafi, Mehrdad Moosazadeh Moghaddam, Mahdi Fasihi-Ramandi & Reza Mirnejad. (2022) A contemporary review on the important role of in silico approaches for managing different aspects of COVID-19 crisis. Informatics in Medicine Unlocked 28, pages 100862.
Crossref
Avinash Kumar, Arpana Parihar, S. Nisar Basha & Udwesh Panda. 2022. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection 451 488 .
Gunderao H. Kathwate. (2022) In silico Design and Characterization of Multi-epitopes Vaccine for SARS-CoV2 from Its Spike Protein. International Journal of Peptide Research and Therapeutics 28:1.
Crossref
Roberto Louis Forestal & Shih‐Ming Pi. (2021) A hybrid approach based on ELECTRE III ‐genetic algorithm and TOPSIS method for selection of optimal COVID ‐19 vaccines . Journal of Multi-Criteria Decision Analysis 29:1-2, pages 80-91.
Crossref
Kamna Srivastava & Mohan Kumar Singh. (2021) Drug repurposing in COVID-19: A review with past, present and future. Metabolism Open 12, pages 100121.
Crossref
Lifei Ma, Huiyang Li, Jinping Lan, Xiuqing Hao, Huiying Liu, Xiaoman Wang & Yong Huang. (2021) Comprehensive analyses of bioinformatics applications in the fight against COVID-19 pandemic. Computational Biology and Chemistry 95, pages 107599.
Crossref
Braira Wahid, Anam Amir, Ayesha Ameen & Muhammad Idrees. (2021) Current status of therapeutic approaches and vaccines for SARS-CoV-2. Future Microbiology 16:17, pages 1319-1326.
Crossref
Bahareh Vakili, Ashkan Bagheri & Manica Negahdaripour. (2021) Deep survey for designing a vaccine against SARS-CoV-2 and its new mutations. Biologia 76:11, pages 3465-3476.
Crossref
Asad Ullah, Sajjad Ahmad, Saba Ismail, Zobia Afsheen, Muhammad Khurram, Muhammad Tahir ul Qamar, Naif AlSuhaymi, Mahdi H. Alsugoor & Khaled S. Allemailem. (2021) Towards A Novel Multi-Epitopes Chimeric Vaccine for Simulating Strong Immune Responses and Protection against Morganella morganii. International Journal of Environmental Research and Public Health 18:20, pages 10961.
Crossref
Admire Dube, Samuel Egieyeh & Mohammed Balogun. (2021) A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa. Viruses 13:10, pages 2095.
Crossref
Dmitry A. Vologzhanin, Aleksandr S. Golota, Tatyana A. Kamilova, Olga V. Shneider & Sergey G. Sсherbak. (2021) Computer simulation in the development of vaccines against covid-19 based on the hla-system antigens. Journal of Clinical Practice 12:3, pages 51-70.
Crossref
Anuj Kumar, Dwijesh Chandra Mishra, Ulavappa Basavanneppa Angadi, Rashmi Yadav, Anil Rai & Dinesh Kumar. (2021) Inhibition Potencies of Phytochemicals Derived from Sesame Against SARS-CoV-2 Main Protease: A Molecular Docking and Simulation Study. Frontiers in Chemistry 9.
Crossref
David V. McLeod, Lindi M. Wahl & Nicole Mideo. (2021) Mosaic vaccination: How distributing different vaccines across a population could improve epidemic control. Evolution Letters 5:5, pages 458-471.
Crossref
Yashpal Singh Malik, Shubhankar Sircar, Sudipta Bhat, Mohd Ikram Ansari, Tripti Pande, Prashant Kumar, Basavaraj Mathapati, Ganesh Balasubramanian, Rahul Kaushik, Senthilkumar Natesan, Sayeh Ezzikouri, Mohamed E. El Zowalaty & Kuldeep Dhama. (2020) How artificial intelligence may help the Covid‐19 pandemic: Pitfalls and lessons for the future. Reviews in Medical Virology 31:5, pages 1-11.
Crossref
Stephanie Ishack & Shari R. Lipner. (2021) Bioinformatics and immunoinformatics to support COVID‐19 vaccine development. Journal of Medical Virology 93:9, pages 5209-5211.
Crossref
Amany Sayed Maghraby. (2021) Immunomodulatory Responses Of Toll Like Receptors Against 2019nCoV. Russian Open Medical Journal 10:2.
Crossref
Andrés Felipe Cuspoca, Laura Lorena Díaz, Alvaro Fernando Acosta, Marcela Katherine Peñaloza, Yardany Rafael Méndez, Diana Carolina Clavijo & Juvenal Yosa Reyes. (2021) An Immunoinformatics Approach for SARS-CoV-2 in Latam Populations and Multi-Epitope Vaccine Candidate Directed towards the World’s Population. Vaccines 9:6, pages 581.
Crossref
Janish Kumar, Rahila Qureshi, Someswar R. Sagurthi & Insaf Ahmed Qureshi. (2020) Designing of Nucleocapsid Protein Based Novel Multi-epitope Vaccine Against SARS-COV-2 Using Immunoinformatics Approach. International Journal of Peptide Research and Therapeutics 27:2, pages 941-956.
Crossref
Mina Mobini Kesheh, Sara Shavandi, Parastoo Hosseini, Rezvan Kakavand-Ghalehnoei & Hossein Keyvani. (2021) Bioinformatic HLA Studies in the Context of SARS-CoV-2 Pandemic and Review on Association of HLA Alleles with Preexisting Medical Conditions. BioMed Research International 2021, pages 1-12.
Crossref
André E. Nel & Jeff F. Miller. (2021) Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape. ACS Nano 15:4, pages 5793-5818.
Crossref
Nidhi Chauhan, Shringika Soni, Abhinandan Gupta, Mohammad Aslam & Utkarsh Jain. (2020) Interpretative immune targets and contemporary position for vaccine development against SARS‐CoV‐2: A systematic review. Journal of Medical Virology 93:4, pages 1967-1982.
Crossref
Sajjad Ahmad, Farah Shahid, Muhammad Tahir ul Qamar, Habib ur Rehman, Sumra Wajid Abbasi, Wasim Sajjad, Saba Ismail, Faris Alrumaihi, Khaled S. Allemailem, Ahmad Almatroudi & Hafiz Fahad Ullah Saeed. (2021) Immuno-Informatics Analysis of Pakistan-Based HCV Subtype-3a for Chimeric Polypeptide Vaccine Design. Vaccines 9:3, pages 293.
Crossref
Rodrigo C. O. Sanches, Sandeep Tiwari, Laís C. G. Ferreira, Flávio M. Oliveira, Marcelo D. Lopes, Maria J. F. Passos, Eduardo H. B. Maia, Alex G. Taranto, Rodrigo Kato, Vasco A. C. Azevedo & Debora O. Lopes. (2021) Immunoinformatics Design of Multi-Epitope Peptide-Based Vaccine Against Schistosoma mansoni Using Transmembrane Proteins as a Target. Frontiers in Immunology 12.
Crossref
Muhammad Waqas, Ali Haider, Abdur Rehman, Muhammad Qasim, Ahitsham Umar, Muhammad Sufyan, Hafiza Nisha Akram, Asif Mir, Roha Razzaq, Danish Rasool, Rana Adnan Tahir & Sheikh Arslan Sehgal. (2021) Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening. BioMed Research International 2021, pages 1-20.
Crossref
Marcelle Moura Silveira, Gustavo Marçal Schmidt Garcia Moreira & Marcelo Mendonça. (2021) DNA vaccines against COVID-19: Perspectives and challenges. Life Sciences 267, pages 118919.
Crossref
Tofael Ahmed Sumon, Md. Ashraf Hussain, Md. Tawheed Hasan, Mahmudul Hasan, Won Je Jang, Eleus Hussain Bhuiya, Abdullah Al Mamun Chowdhury, S. M. Sharifuzzaman, Christopher Lyon Brown, Hyun-Ju Kwon & Eun-Woo Lee. (2021) A Revisit to the Research Updates of Drugs, Vaccines, and Bioinformatics Approaches in Combating COVID-19 Pandemic. Frontiers in Molecular Biosciences 7.
Crossref
Mohamed M. Aboudounya & Richard J. Heads. (2021) COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation. Mediators of Inflammation 2021, pages 1-18.
Crossref
Elijah Kolawole Oladipo, Ayodeji Folorunsho Ajayi, Olugbenga Samson Onile, Olumuyiwa Elijah Ariyo, Esther Moradeyo Jimah, Louis Odinakaose Ezediuno, Oluwadunsin Iyanuoluwa Adebayo, Emmanuel Tayo Adebayo, Aduragbemi Noah Odeyemi, Marvellous Oluwaseun Oyeleke, Moyosoluwa Precious Oyewole, Ayomide Samuel Oguntomi, Olawumi Elizabeth Akindiya, Victoria Oyetayo Aremu, Dorcas Olubunmi Aboderin & Julius Kola Oloke. (2021) Designing a conserved peptide-based subunit vaccine against SARS-CoV-2 using immunoinformatics approach. In Silico Pharmacology 9:1.
Crossref
Vitor R. C. Aguiar, Danillo G. Augusto, Erick C. Castelli, Jill A. Hollenbach, Diogo Meyer, Kelly Nunes & Maria Luiza Petzl-Erler. (2021) An immunogenetic view of COVID-19. Genetics and Molecular Biology 44:1 suppl 1.
Crossref
T. Wibawa. (2020) COVID‐19 vaccine research and development: ethical issues. Tropical Medicine & International Health 26:1, pages 14-19.
Crossref
Renu Jakhar, Neelam Sehrawat & S. K. Gakhar. 2021. Computational Intelligence Techniques for Combating COVID-19. Computational Intelligence Techniques for Combating COVID-19 159 184 .
Xueqing Wang & Yuanfang Guan. (2020) COVID‐19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays. Medicinal Research Reviews 41:1, pages 5-28.
Crossref
Nidhi Singh, Sachchida Nand Rai, Veer Singh & Mohan P. Singh. (2020) Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19. Journal of Chemical Neuroanatomy 110, pages 101874.
Crossref
Samira Sanami, Milad Zandi, Behzad Pourhossein, Gholam-Reza Mobini, Mohsen Safaei, Atena Abed, Pooria Mohammadi Arvejeh, Fatemeh Amini Chermahini & Morteza Alizadeh. (2020) Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach. International Journal of Biological Macromolecules 164, pages 871-883.
Crossref
M Sreepadmanabh, Amit Kumar Sahu & Ajit Chande. (2020) COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development. Journal of Biosciences 45:1.
Crossref
Ashkan Safavi, Amirhosein Kefayat, Elham Mahdevar, Ardavan Abiri & Fatemeh Ghahremani. (2020) Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Vaccine 38:48, pages 7612-7628.
Crossref
Ishtiaque Ahammad & Samia Sultana Lira. (2020) Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach. International Journal of Biological Macromolecules 162, pages 820-837.
Crossref
Xingwu Zhou, Xing Jiang, Moyuan Qu, George E. AninweneIIII, Vadim Jucaud, James J. Moon, Zhen Gu, Wujin Sun & Ali Khademhosseini. (2020) Engineering Antiviral Vaccines. ACS Nano 14:10, pages 12370-12389.
Crossref
Niloofar Khairkhah, Mohammad Reza Aghasadeghi, Ali Namvar & Azam Bolhassani. (2020) Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis. PLOS ONE 15:10, pages e0240577.
Crossref
Nanda Kumar Yellapu, Shachi Patel, Bo Zhang, Richard Meier, Lisa Neums, Dong Pei, Qing Xia, Duncan Rotich, Rosalyn C. Zimmermann, Emily Nissen, Shelby Bell-Glenn, Whitney Shae, Jinxiang Hu, Prabhakar Chalise, Lynn Chollet-Hinton, Devin C. Koestler & Jeffery A. Thompson. (2020) Evolutionary Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reveals Genomic Divergence with Implications for Universal Vaccine Efficacy. Vaccines 8:4, pages 591.
Crossref
Abhishek Singh, Mukesh Thakur, Lalit Kumar Sharma & Kailash Chandra. (2020) Designing a multi-epitope peptide based vaccine against SARS-CoV-2. Scientific Reports 10:1.
Crossref
Mujahed I. Mustafa, Abdelrahman H. Abdelmoneim, Eiman M. Mahmoud & Abdelrafie M. Makhawi. (2020) Cytokine Storm in COVID-19 Patients, Its Impact on Organs and Potential Treatment by QTY Code-Designed Detergent-Free Chemokine Receptors. Mediators of Inflammation 2020, pages 1-7.
Crossref
Haneen Amawi, Ghina'a I Abu Deiab, Alaa A A Aljabali, Kamal Dua & Murtaza M Tambuwala. (2020) COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Therapeutic Delivery 11:4, pages 245-268.
Crossref
Sahar Obi Abd Albagi, Mosab Yahya Al-Nour, Mustafa Elhag, Asaad Tageldein Idris Abdelihalim, Esraa Musa Haroun, Mohammed Elmujtba Adam Essa, Mustafa Abubaker, Hemchandra Deka, Arabinda Ghosh & Mohammed A. Hassan. (2020) A multiple peptides vaccine against COVID-19 designed from the nucleocapsid phosphoprotein (N) and Spike Glycoprotein (S) via the immunoinformatics approach. Informatics in Medicine Unlocked 21, pages 100476.
Crossref
Mahnoor Malik, Asad Ullah, Mahboob ul Haq, Samira Sanami, Sajjad Ahmad, Saifullah Khan, Alhanouf I. Al-Harbi, Syed Ainul Abideen, Muhammad Irfan, Zobia Afsheen & Muhammad Khurram. (2022) Proteome Wide Screening of Potential Vaccine Targets Against Brucella Melitensis. SSRN Electronic Journal.
Crossref
Muhammad Saqib Sohail, Syed Faraz Ahmed, Ahmed Abdul Quadeer & Matthew McKay. (2020) In Silico T Cell Epitope Identification for SARS-CoV-2: Progress and Perspectives. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.